This is certainly interesting!
Australian biotech firm Starpharma has developed an antiviral compound called VivaGel that laboratory tests have shown can inactivate up to 99.9 per cent of HIV, herpes and some other sexually transmitted viruses, reducing the risk of transmission.
The Australian firm has teamed up with the world’s second biggest condom maker, Australian-based Ansell, to come up with a range that incorporates this antiviral coating in the lubricant. According to reports, the Australian-developed virus-killing condom is a step closer to sale, following a key regulatory approval.
The condoms have now received Conformity Assessment Certification from Australia’s Therapeutic Goods Administration (TGA). Starpharma’s chief executive Dr Jackie Fairley says this approval means that the condoms should be available to consumers in Australia within months.
If this is tested and tried and found to be effective we wonder how long before the rest of the world gets in on the action of HIV-killing condoms.